Compare like-for-like revenue
The reported-period revenue series records ILS 70.09m for the period ended March 31, 2026. That is 7.8% above the same reporting basis a year earlier.
—
—
—
Intercure Ltd.
—
—
Live Price
CIN RESEARCH · DATED EVIDENCE
Dated financial evidenceIntercure Ltd.: revenue expanded; follow the cash evidence.
The reported-period revenue series records ILS 70.09m for the period ended March 31, 2026. That is 7.8% above the same reporting basis a year earlier. Cash and operating cash flow are available on a matching dated basis.
Latest financial observation 2026-03-31Price history through 2026-11-05Research checked 2026-11-06 13:30 UTC
The check time records a research refresh. Each financial figure and price keeps its own reporting date.
Put cash beside operating cash flow
Period-end cash was ILS 46.47m at 2026-03-31. The matching reported-period operating cash inflow was ILS 16.84m. Later financing and cash movements are not established by this snapshot.
Follow the primary disclosures
The available record includes 2 primary disclosures. The latest is 2026-06-22. This is the available feed record, not a claim of complete filing coverage.
Reported financial evidence
| Measure | Reported value & unit | Period & interval | Evidence basis |
|---|---|---|---|
| Revenue | ILS 70.09mUnit: ILS | Quarterly series | Dated financial series |
| Cost of revenue | ILS 69.86mUnit: ILS | Quarterly series | Dated financial series |
| Gross profit | ILS 239,500Unit: ILS | Quarterly series | Dated financial series |
| Operating income | ILS -16.48mUnit: ILS | Quarterly series | Dated financial series |
| EBITDA | ILS -34.8mUnit: ILS | Quarterly series | Dated financial series |
| Cash balance | ILS 46.47mUnit: ILS | Balance at period end | Dated financial series |
| Total assets | ILS 690.55mUnit: ILS | Balance at period end | Dated financial series |
| Total liabilities | ILS 294.2mUnit: ILS | Balance at period end | Dated financial series |
| Shareholders’ equity | ILS 396.52mUnit: ILS | Balance at period end | Dated financial series |
| Operating cash flow | ILS 16.84mUnit: ILS | Quarterly series | Dated financial series |
| Free cash flow | ILS 13.29mUnit: ILS | Quarterly series | Dated financial series |
A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.
What changed against the prior year
Only the same measure, unit, reporting frequency and prior-year period end are compared. A reported change is not an investment rating.
Increased +7.8%
- 2025-03-31
- ILS 65,005,500
- 2026-03-31
- ILS 70,094,500
Increased +55.6%
- 2025-03-31
- ILS 44,894,000
- 2026-03-31
- ILS 69,855,000
Decreased -98.8%
- 2025-03-31
- ILS 20,111,500
- 2026-03-31
- ILS 239,500
Decreased -676.6%
- 2025-03-31
- ILS 2,858,000
- 2026-03-31
- ILS -16,480,000
Decreased -588.4%
- 2025-03-31
- ILS 7,125,000
- 2026-03-31
- ILS -34,796,500
Decreased -9.5%
- 2025-03-31
- ILS 51,334,000
- 2026-03-31
- ILS 46,466,000
Decreased -8.1%
- 2025-03-31
- ILS 751,763,000
- 2026-03-31
- ILS 690,552,000
Decreased -7.9%
- 2025-03-31
- ILS 319,519,000
- 2026-03-31
- ILS 294,195,000
Decreased -8%
- 2025-03-31
- ILS 431,147,000
- 2026-03-31
- ILS 396,521,000
Increased +176.1%
- 2025-03-31
- ILS 6,099,000
- 2026-03-31
- ILS 16,841,000
Increased +196.9%
- 2025-03-31
- ILS 4,476,500
- 2026-03-31
- ILS 13,292,000
What to investigate next
- Resolve the conflicting financial observations against the primary report.
- Confirm the financial-statement currency against the original report; the listing currency is different.
- Read the latest linked company disclosures and any reporting after the financial period.
- Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.
Evidence boundaries
- Conflicting observations for the same concept, period and reporting basis are withheld.
- Financial-statement units differ from the listing currency. Values are kept in their reported units; valuation and cross-currency comparisons are withheld.
- Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
- The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.
Primary company disclosures
Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →
Price History · currency not supplied
5 Years
Fundamentals
SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
CONTINUE YOUR RESEARCH